Breaking News
March 23, 2019 - Toilet seat heart monitoring system
March 23, 2019 - Researchers identify way to improve common treatment for PTSD
March 23, 2019 - High potency cannabis use linked to psychosis finds study
March 23, 2019 - Evoke Pharma Submits Response to FDA Review Letter for Gimoti NDA
March 23, 2019 - Tracking HIV’s ever-evolving genome in effort to prioritize public health resources
March 23, 2019 - Scientists grow most sophisticated brain organoid to date
March 23, 2019 - ADHD drug raising risk of psychosis
March 22, 2019 - FDA approves brexanolone, first drug developed to treat postpartum depression
March 22, 2019 - Gruesome cat and dog experiments by the USDA exposed
March 22, 2019 - Ball pits used in children’s physical therapy may contribute to germ transmission
March 22, 2019 - Long-term use of inexpensive weight-loss drug may be safe and effective
March 22, 2019 - FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
March 22, 2019 - Anti-Müllerian Hormone Test: MedlinePlus Lab Test Information
March 22, 2019 - Finding the right exercise, diet aids for HIV patients
March 22, 2019 - Health Plans For State Employees Use Medicare’s Hammer On Hospital Bills
March 22, 2019 - Researchers develop new tool for imaging large groups of neurons in living animals
March 22, 2019 - Certain bacteria and immune factors in vagina may cause or protect against preterm birth
March 22, 2019 - Novel breath test could pave new way to non-invasively measure gut health
March 22, 2019 - Pharmaceutical and personal care products may result in new contaminants in waterways
March 22, 2019 - ACC: Catheter Ablation Does Not Cut Mortality, Stroke in A-Fib
March 22, 2019 - Wiedemann-Rautenstrauch syndrome – Genetics Home Reference
March 22, 2019 - Health insurance is not assurance of healthcare
March 22, 2019 - Supporting “curiosity-driven research” at the Discovery Innovation Awards
March 22, 2019 - Must-Reads Of The Week (Some Flying Below The Radar)
March 22, 2019 - Newly engineered nanoscale protein micelles can be tracked by MRI
March 22, 2019 - Mayo Clinic study identifies potential new drug therapy for liver diseases
March 22, 2019 - Pitt engineers win $550,000 NSF CAREER award to develop new intervention for people with ASD
March 22, 2019 - Early discharge does not increase readmission risk for patients after lung surgery
March 22, 2019 - Creating diverse pool of trained scientists to address Alzheimer’s research needs
March 22, 2019 - Surprising discovery offers clues to limit graft-vs.-host disease
March 22, 2019 - Study shows ACA’s positive impact on healthcare affordability and access for women
March 22, 2019 - Study provides new pathway for controlling inflammation
March 22, 2019 - New combination treatment shows promise for common brain tumor in children
March 22, 2019 - Virginia Tech Helmet Lab releases first youth-specific football helmet ratings
March 22, 2019 - New algae-based treatment could reduce need for limb amputation
March 22, 2019 - Stroke risk reduces in both black and white older Medicare beneficiaries, study reports
March 22, 2019 - City of Hope exhibits current studies and data on cancer therapies at AACR
March 22, 2019 - New study identifies CD40 molecule as key entry point for dangerous bacteria
March 22, 2019 - Health Tip: Six Steps to a Healthier Life
March 22, 2019 - even a little activity helps you live longer
March 22, 2019 - Many individuals recovering from addiction continue to suffer from chronic physical disease
March 22, 2019 - New drugs on PBS for Parkinson’s, MND and Cutaneous T cell lymphoma
March 22, 2019 - Saving energy also saves lives, UW-Madison study says
March 22, 2019 - Former inmates who receive social support have better mental health, study finds
March 22, 2019 - Nanofibrous membrane could enhance periodontal tissue regeneration
March 22, 2019 - Anti-vaxxer Italian leader down with chickenpox
March 22, 2019 - Servier collaborates with Harvard researchers to fight metabolic diseases
March 22, 2019 - National Eating Disorders Association
March 22, 2019 - Pumping up red blood cell production
March 22, 2019 - Excessive phosphate fertilizer may hurt plants by altering microbial composition in soil
March 22, 2019 - Medical marijuana laws could be improving older Americans’ health, study suggests
March 22, 2019 - Study indicates the benefits of stopping aspirin in heart attack patients
March 22, 2019 - Deep brain stimulation offers significant relief for patients with treatment-resistant depression
March 22, 2019 - Mental health problems in young adults on the rise
March 22, 2019 - Innovative membrane offers a viable solution for periodontitis
March 22, 2019 - The FDA Grants Rare Pediatric Disease Designation to Odiparcil for the Treatment of MPS VI
March 22, 2019 - insulin therapy: MedlinePlus Medical Encyclopedia
March 22, 2019 - Guidelines on the use of genetic testing in psychiatry
March 22, 2019 - Aspiring Doctors Seek Advanced Training In Addiction Medicine
March 22, 2019 - A change in focus could enable the development of new treatments for Alzheimer’s disease
March 22, 2019 - A new way to visualize the immune cell “landscape” of bowel cancer tumors
March 22, 2019 - Understanding maintenance of quiescent stem cells in chronic myelogenous leukemia
March 22, 2019 - Ludwig scientists to share advances in cancer research at AACR Annual Meeting 2019
March 22, 2019 - Less invasive valve replacement can be safe and effective alternative for healthier patients
March 22, 2019 - Aphasia research reveals new, complex interactions between thought and language
March 22, 2019 - Artificial neural networks can predict how different areas in the brain respond to words
March 22, 2019 - Age-related changes to gut microbiome have adverse impact on vascular health, study shows
March 22, 2019 - Study provides new insight into blood cell and immune cell production
March 22, 2019 - Isolated seniors chat online to prevent cognitive decline
March 22, 2019 - Repurposing drugs to outsmart cancers
March 22, 2019 - Naltrexone implant more effective in reducing relapses in HIV patients with opioid addiction
March 22, 2019 - The Brain Institute wins $7.04 million grant to investigate ‘neurophilosphy of free will’
March 22, 2019 - Karyopharm Announces FDA Extension of Review Period for Selinexor New Drug Application
March 22, 2019 - Eruptive xanthomatosis
March 22, 2019 - Cause of vascular disease in kidney failure reversed in animal model
March 22, 2019 - Researchers discover possible new therapeutic strategy for pancreatic cancer
March 22, 2019 - Ebola spreads to second largest city in DRC
March 22, 2019 - Perivascular spaces contribute to worse cognitive health in older adults
March 22, 2019 - Adolescent daily users more likely to obtain electronic cigarettes from commercial sources
March 22, 2019 - FDA Approves Genentech’s Tecentriq in Combination With Chemotherapy for the Initial Treatment of Adults With Extensive-Stage Small Cell Lung Cancer
Cancer cells could be detected irrespective of site and type using simple test

Cancer cells could be detected irrespective of site and type using simple test

image_pdfDownload PDFimage_print

Australian researchers have found that cells containing cancer could soon be detected using a simple test. The test could one day change how cancers are diagnosed, the team says. The results of the study to develop the test were published in the journal Nature Communications.

Cancer cells in their early stages have certain DNA signatures, the team noted that make them unique. They said that the DNA from different types of cancers contain signatures which could act as cancer markers. They add that the team is developing the test so that it could be used for screening of cancers especially in early stages.

Researchers at the University of Queensland have developed a simple test to see if there are DNA changes in the cells from blood and biopsy tissue. Matt Trau, one of the researchers, said that it was difficult to find a “simple marker” that could differentiate between cancer cells and healthy cells. He said, “We never thought this would be possible, because cancer is so complicated.” He said that they initially believed that each cancer would need a separate test for detection. The team then noted that this novel marker was present in all types of breast cancer, colorectal or bowel cancer, prostate cancer and lymphomas.

Prof Trau said the results “stunned” them and they realized that this was a “general feature for all cancer.” Trau explained that they relied on epigenetics and found that there were changes in the DNA that could control the functions of the cells. “Usually, the approach to find cancer markers … is to look at the sequence of DNA,” he explained. For this test, he said, they looked at patterns of methyl groups over the DNA. These groups act as switches that switch the genes on and off and are called epigenomes. They are instructions that control the expressions of the genes.

The team found that in the healthy cells these methyl groups are spread across the genome. Among the cancer cells they noted that the methyl groups are in clusters at specific regions. Trau said, “Virtually every piece of cancerous DNA we examined had this highly predictable pattern… If you think of a cell as a hard-drive … the epigenome is sort of like the apps the cell is running at any one moment. It seems that to launch cancer, you have to run a series of genetic apps.” The test would help the scientists detect the cancer cells by identifying these patterns of spread of the methyl groups or the epigenetic patterns.

The team used cancerous DNA molecules and placed it in a chemical solution that let it to fold in complex 3D structures. These complex structures depending upon the epigenetic pattern would then stick to gold nanoparticles used for the test. This changes the colour of the solution containing the nanoparticles and this change can be detected with the “naked eye” said Trau. The team tested the test on 200 samples of cancer cells and found that the test was accurate in 90 percent cases. The test however can detect only the presence of the cancer and not the site of the cancer, stage of the cancer or the type of the cancer.

Gold nanoparticles produced by laser ablation in heavy water. Scale bar denotes twenty nanometers (20 nm). Image Credit: Georgy Shafeev / Shutterstock

Gold nanoparticles produced by laser ablation in heavy water. Scale bar denotes twenty nanometers (20 nm). Image Credit: Georgy Shafeev / Shutterstock

“A major advantage of this technique is that it is very cheap and extremely simple to do, so it could be adopted in the clinic quite easily,” said Laura Carrascosa, a researcher at the University of Queensland. She said, “Our technique could be a screening tool to inform clinicians that a patient may have a cancer, but they would require subsequent tests with other techniques to identify the cancer type and stage.”

The study was funded by the National Breast Cancer Foundation and was supported by University of Queensland’s commercialisation company UniQuest which is helping develop the technology. Professor Trau said that the next step would be to start clinical trials to hone the test. “We certainly don’t know yet whether it’s the holy grail for all cancer diagnostics, but it looks really interesting,” he concluded.

Source:

https://www.nature.com/articles/s41467-018-07214-w

Tagged with:

About author

Related Articles